Browse the corpus

Walk the evidence base by book and chapter — the raw source passages that ground Ask, Differential, and the rest.

• 3D T1-weighted black blood sequence at 3.0 Tesla for the diagnosis of cervical artery dissection.1 passage
• A literature review of cost-effectiveness of intravenous recombinant tissue plasminogen activator for treating acute ischemic stroke.1 passage
• ABCD1 passage
• AHORA: a Spanish language tool to identify acute stroke symptoms.1 passage
• Acute Ischaemic Stroke Cooperation Group of Endovascular Treatment (ANGEL) registry: study protocol for a prospective, multicentre registry in China.1 passage
• Acute cerebrovascular disease following COVID-19: a single center, retrospective, observational study.1 passage
• Acute ischaemic stroke interventions: large vessel occlusion and beyond.1 passage
• Additive effect of cerebral atrophy on cognition in dementia-free elderly with cerebrovascular disease.1 passage
• Adenosine to facilitate the clipping of cerebral aneurysms: literature review.1 passage
• Advances in endovascular aneurysm management: coiling and adjunctive devices.1 passage
• Advances in endovascular aneurysm management: flow modulation techniques with braided mesh devices.1 passage
• Advances in mechanical thrombectomy for acute ischaemic stroke from large vessel occlusions.1 passage
• Ambulatory blood pressure profile and stroke recurrence.1 passage
• Analytical validation of GMEX rapid point-of-care1 passage
• Antiplatelet Therapy in Acute Mild-Moderate Ischemic Stroke (ATAMIS): a parallel, randomised, open-label, multicentre, prospective study.1 passage
• Appropriate management of asymptomatic carotid stenosis.1 passage
• Are you suffering from a large arterial occlusion? Please raise your arm!1 passage
• Arterial stiffness and stroke: de-stiffening strategy, a therapeutic target for stroke.1 passage
• Association between admission haematocrit and mortality among men with acute ischaemic stroke.1 passage
• Association between coexisting intracranial artery and extracranial carotid artery atherosclerotic diseases and ipsilateral cerebral infarction: a Chinese Atherosclerosis Risk Evaluation (CARE-II) study.1 passage
• Association between fluid-attenuated inversion recovery vascular hyperintensity and outcome varies with different lesion patterns in patients with intravenous thrombolysis.1 passage
• Association between large artery atherosclerosis and cerebral microbleeds: a systematic review and meta-analysis.1 passage
• Association of elevated hs-CRP and multiple infarctions with outcomes of minor stroke or TIA: subgroup analysis of CHANCE randomised clinical trial.1 passage
• Association of homocysteine and smoking with cerebral microemboli in patients with mechanical heart valves: a transcranial Doppler study.1 passage
• Associations of blood biomarkers with glomerular filtration rate in patients with TIA and stroke: population-based study.1 passage
• B vitamins for stroke prevention.1 passage
• Big data and artificial intelligence discover novel drugs targeting proteins without 3D structure and overcome the undruggable targets.1 passage
• Biomechanical thrombosis: the dark side of force and dawn of mechano-medicine.1 passage
• Blood pressure gradients in cerebral arteries: a clue to pathogenesis of cerebral small vessel disease.1 passage
• Blood pressure management in acute stroke.1 passage
• Body mass index and clinical outcomes in patients with intracerebral haemorrhage: results from the China Stroke Center Alliance.1 passage
• Brain iron overload following intracranial haemorrhage.1 passage
• CCM3 and cerebral cavernous malformation disease.1 passage
• CO1 passage
• Cardiac natriuretic peptides for diagnosis of covert atrial fibrillation after acute ischaemic stroke: a meta-analysis of diagnostic accuracy studies.1 passage
• Cardioembolic stroke: everything has changed.1 passage
• Carotid endarterectomy for treatment of carotid in-stent restenosis: long-term follow-up results and surgery experiences from one single centre.1 passage
• Carotid stenosis in women: time for a reappraisal.1 passage
• Cellular and molecular imaging for stem cell tracking in neurological diseases.1 passage
• Cerebral aneurysm treatment: modern neurovascular techniques.1 passage
• Cerebral microhaemorrhage in COVID-19: a critical illness related phenomenon?1 passage
• Cerebral microvascular dysfunction and neurodegeneration in dementia.1 passage
• Cerebral misery perfusion due to carotid occlusive disease.1 passage
• Cerebral small vessel disease or intracranial large vessel atherosclerosis may carry different risk for future strokes.1 passage
• Cerebral venous sinus thrombosis after ChAdOx1 nCov-19 vaccination with a misleading first cerebral MRI scan.1 passage
• Changing the strategy and culture of stroke awareness education in China: implementing Stroke 1-2-0.1 passage
• Characteristics, management and response to alteplase in China versus non-China participants of the ENCHANTED trial.1 passage
• Childhood strokes in China describing clinical characteristics, risk factors and performance indicators: a case-series study.1 passage
• China Antihypertensive Trial in Acute Ischemic Stroke II (CATIS-2): rationale and design.1 passage
• China Stroke Statistics 2019: A Report From the National Center for Healthcare Quality Management in Neurological Diseases, China National Clinical Research Center for Neurological Diseases, the Chinese Stroke Association, National Center for Chronic and Non-communicable Disease Control and Prevention, Chinese Center for Disease Control and Prevention and Institute for Global Neuroscience and Stroke Collaborations.1 passage
• Chinese Atherosclerosis Risk Evaluation (CARE II) study: a novel cross-sectional, multicentre study of the prevalence of high-risk atherosclerotic carotid plaque in Chinese patients with ischaemic cerebrovascular events-design and rationale.1 passage
• Chinese Stroke Association guidelines for clinical management of cerebrovascular disorders: executive summary and 2019 update of clinical management of cerebral venous sinus thrombosis.1 passage
• Chinese Stroke Association guidelines for clinical management of cerebrovascular disorders: executive summary and 2019 update of clinical management of intracerebral haemorrhage.1 passage
• Chinese Stroke Association guidelines for clinical management of cerebrovascular disorders: executive summary and 2019 update of clinical management of ischaemic cerebrovascular diseases.1 passage
• Chinese Stroke Association guidelines for clinical management of cerebrovascular disorders: executive summary and 2019 update of clinical management of spontaneous subarachnoid haemorrhage.1 passage
• Chinese Stroke Association guidelines for clinical management of cerebrovascular disorders: executive summary and 2019 update of clinical management of stroke rehabilitation.1 passage
• Chinese Stroke Association guidelines for clinical management of cerebrovascular disorders: executive summary and 2019 update of the management of high-risk population.1 passage
• Chinese Stroke Association guidelines for clinical management of cerebrovascular disorders: executive summary and 2019 update on organizational stroke management.1 passage
• Chinese Stroke Center Alliance: a national effort to improve healthcare quality for acute stroke and transient ischaemic attack: rationale, design and preliminary findings.1 passage
• Cilostazol for secondary stroke prevention: systematic review and meta-analysis.1 passage
• Circle of Willis variants are not associated with thrombectomy outcomes.1 passage
• Classification of brain arteriovenous malformations located in motor-related areas based on location and anterior choroidal artery feeding.1 passage
• Clinical features of seizures after cerebral venous sinus thrombosis and its effect on outcome among Chinese Han population.1 passage
• Clinical imaging factors of excellent outcome after thrombolysis in large-vessel stroke: a THRACE subgroup analysis.1 passage
• Clinical time course of COVID-19, its neurological manifestation and some thoughts on its management.1 passage
• Clinician's perspectives in using head impulse-nystagmus-test of skew (HINTS) for acute vestibular syndrome: UK experience.1 passage
• Clopidogrel loading dose versus maintenance dose to treat patients with acute ischaemic stroke in China (CLASS-China): results from a prospective double-blind randomised clinical trial.1 passage
• Clopidogrel with aspirin in High-risk patients with Acute Non-disabling Cerebrovascular Events II (CHANCE-2): rationale and design of a multicentre randomised trial.1 passage
• Coagulopathy reversal in intracerebral haemorrhage.1 passage
• Combined risk modelling approach to identify the optimal carotid revascularisation approach.1 passage
• Comparative effectiveness of combined antiplatelet treatments in acute minor ischaemic stroke.1 passage
• Comparison of carotid atherosclerotic plaques between subjects in Northern and Southern China: a Chinese atherosclerosis risk evaluation study.1 passage
• Comparison of outcome of patients with acute minor ischaemic stroke treated with intravenous t-PA, DAPT or aspirin.1 passage
• Comparison of two bedside evaluation methods of dysphagia in patients with acute stroke.1 passage
• Concurrent intracranial and extracranial artery stenosis and the prognosis of transient ischaemic symptoms or imaging-negative ischaemic stroke.1 passage
• Consensus for prevention and management of coronavirus disease 2019 (COVID-19) for neurologists.1 passage
• Contribution of diffusion, perfusion and functional MRI to the disconnection hypothesis in subcortical vascular cognitive impairment.1 passage
• Controlling resistant hypertension.1 passage
• Cumulative burden of lipid profiles predict future incidence of ischaemic stroke and residual risk.1 passage
• Current management of spontaneous intracerebral haemorrhage.1 passage
• Current status of intravenous tissue plasminogen activator dosage for acute ischaemic stroke: an updated systematic review.1 passage
• Decline in stroke alerts and hospitalisations during the COVID-19 pandemic.1 passage
• Decline in subarachnoid haemorrhage volumes associated with the first wave of the COVID-19 pandemic.1 passage
• Deep learning for automatically predicting early haematoma expansion in Chinese patients.1 passage
• Determinants of the impact of blood pressure variability on neurological outcome after acute ischaemic stroke.1 passage
• Development and validation of a novel nomogram to predict aneurysm rupture in patients with multiple intracranial aneurysms: a multicentre retrospective study.1 passage
• Diet for stroke prevention.1 passage
• Diet quality in patients with stroke.1 passage
• Differences in atheroma between Caucasian and Asian subjects with anterior stroke: A vessel wall MRI study.1 passage
• Different aspects of cognitive function in adult patients with moyamoya disease and its clinical subtypes.1 passage
• Different contribution of SBP and DBP variability to vascular events in patients with stroke.1 passage
• Digital subtraction angiographic characteristics of progression of moyamoya disease 6 months prior to surgical revascularisation.1 passage
• Direct carotid puncture in acute ischaemic stroke intervention.1 passage
• Donning and doffing of personal protective equipment protocol and key points of nursing care for patients with COVID-19 in ICU.1 passage
• Dual antiplatelet therapy may increase the risk of non-intracranial haemorrhage in patients with minor strokes: a subgroup analysis of the CHANCE trial.1 passage
• Dual versus mono antiplatelet therapy for acute non-cardioembolic ischaemic stroke or transient ischaemic attack: a systematic review and meta-analysis.1 passage
• Dynamic contrast-enhanced MRI analysis for prognosis of intracranial dissecting aneurysm with intramural haematoma after endovascular treatment: an observational registry study.1 passage
• Early cisternal fibrinolysis is more effective than rescue spasmolysis for the prevention of delayed infarction after subarachnoid haemorrhage.1 passage
• Effect of sex differences on prognosis of intravenous thrombolysis: data from the Thrombolysis Implementation and Monitor of Acute Ischemic Stroke in China (TIMS-China).1 passage
• Effect of thrombectomy on oedema progression and clinical outcome in patients with a poor collateral profile.1 passage
• Effectiveness of intravenous r-tPA versus UK for acute ischaemic stroke: a nationwide prospective Chinese registry study.1 passage
• Effects and safety of aspirin use in patients after cerebrovascular bypass procedures.1 passage
• Effects of vitamin E on stroke: a systematic review with meta-analysis and trial sequential analysis.1 passage
• Efficacy and safety of bridging thrombolysis initiated before transfer in a drip-and-ship stroke service.1 passage
• Efficacy and safety of intravenous recombinant tissue plasminogen activator in mild ischaemic stroke: a meta-analysis.1 passage
• Emergency medical services use and its association with acute ischaemic stroke evaluation and treatment in Singapore.1 passage
• Endarterectomy for symptomatic non-stenotic carotids: a systematic review and descriptive analysis.1 passage
• Endarterectomy versus stenting for stroke prevention.1 passage
• Endovascular revascularisation of acute tandem vertebrobasilar artery occlusion: seven case series with literature reviews.1 passage
• Endovascular therapy for Acute ischemic Stroke Trial (EAST): study protocol for a prospective, multicentre control trial in China.1 passage
• Endovascular thrombectomy for stroke: current best practice and future goals.1 passage
• Endovascular treatment in anterior circulation stroke beyond 6.5 hours after onset or time last seen well: results from the MR CLEAN Registry.1 passage
• Endovascular treatment of bilateral intracranial vertebral artery aneurysms: an algorithm based on a 10-year neurointerventional experience.1 passage
• Endovascular treatment of patients with high-risk symptomatic intracranial vertebrobasilar stenoses: long - term outcomes.1 passage
• Endovascular treatment with or without intravenous alteplase for acute ischaemic stroke due to basilar artery occlusion.1 passage
• Exercise for stroke prevention.1 passage
• Expert consensus on prevention and control of COVID-19 in the neurological intensive care unit (first edition).1 passage
• Eyes and stroke: the visual aspects of cerebrovascular disease.1 passage
• Flow diversion covering the M1 origin as a last resort.1 passage
• GRP per capita and hospital characteristics associated with intravenous tissue plasminogen activator adherence rate: evidence from the Chinese Stroke Center Alliance.1 passage
• Gastrointestinal bleeding during acute ischaemic stroke hospitalisation increases the risk of stroke recurrence.1 passage
• Gene panel for Mendelian strokes.1 passage
• Genome sequencing reveals the role of rare genomic variants in Chinese patients with symptomatic intracranial atherosclerotic disease.1 passage
• Ginkgo biloba extract improved cognitive and neurological functions of acute ischaemic stroke: a randomised controlled trial.1 passage
• Guidelines for evaluation and management of cerebral collateral circulation in ischaemic stroke 2017.1 passage
• H1 passage
• Haemodynamic analysis of adult patients with moyamoya disease: CT perfusion and DSA gradings.1 passage
• Haemostatic therapy in spontaneous intracerebral haemorrhage patients with high-risk of haematoma expansion by CT marker: a systematic review and meta-analysis of randomised trials.1 passage
• Headache in cerebrovascular diseases.1 passage
• High HbA1c is associated with higher risk of ischaemic stroke in Pakistani population without diabetes.1 passage
• High-resolution MRI of intracranial large artery diseases: how to use it in clinical practice?1 passage
• How to identify which patients with asymptomatic carotid stenosis could benefit from endarterectomy or stenting.1 passage
• Hyperdense artery sign, symptomatic infarct swelling and effect of alteplase in acute ischaemic stroke.1 passage
• Identifying sex-specific differences in the carotid revascularisation literature: findings from a scoping review.1 passage
• Impact of COVID-2019 on stroke services in China: survey from the Chinese Stroke Association.1 passage
• Impact of aspiration catheter size on first-pass effect in the combined use of contact aspiration and stent retriever technique.1 passage
• Impairment of cognition and sleep after acute ischaemic stroke or transient ischaemic attack in Chinese patients: design, rationale and baseline patient characteristics of a nationwide multicentre prospective registry.1 passage
• Implementation of regional Acute Stroke Care Map increases thrombolysis rates for acute ischaemic stroke in Chinese urban area in only 3 months.1 passage
• In-hospital complications affect short-term and long-term mortality in ICH: a prospective cohort study.1 passage
• Incidence and outcomes of intracerebral haemorrhage with mechanical compression hydrocephalus.1 passage
• Incidence and prevalence of moyamoya disease in urban China: a nationwide retrospective cohort study.1 passage
• Incidence, prevalence and risk of stroke in patients with Takayasu arteritis: a nationwide population-based study in South Korea.1 passage
• Inconsistent centralised versus non-centralised ischaemic stroke aetiology.1 passage
• Insomnia is associated with increased mortality in patients with first-ever stroke: a 6-year follow-up in a Chinese cohort study.1 passage
• Intracerebral haemorrhage: from clinical settings to animal models.1 passage
• Intravenous tirofiban therapy for patients with capsular warning syndrome.1 passage
• Iron toxicity, lipid peroxidation and ferroptosis after intracerebral haemorrhage.1 passage
• Ischaemic stroke etiological classification system: the agreement analysis of CISS, SPARKLE and TOAST.1 passage
• It is safe to use transdermal glyceryl trinitrate to lower blood pressure in patients with acute ischaemic stroke with carotid stenosis.1 passage
• Lesion-symptom mapping with NIHSS sub-scores in ischemic stroke patients.1 passage
• Linking the Paul Coverdell National Acute Stroke Program to commercial claims to establish a framework for real-world longitudinal stroke research.1 passage
• Long-term outcomes of brainstem arteriovenous malformations after different management modalities: a single-centre experience.1 passage
• Loss of Wip1 aggravates brain injury after ischaemia/reperfusion by overactivating microglia.1 passage
• Low serum albumin levels predict poor outcome in patients with acute ischaemic stroke or transient ischaemic attack.1 passage
• Low-dose intravenous tissue plasminogen activator for acute ischaemic stroke: an alternative or a new standard?1 passage
• Lower lymphocyte to monocyte ratio is a potential predictor of poor outcome in patients with cerebral venous sinus thrombosis.1 passage
• Lower risk of subarachnoid haemorrhage in diabetes: a nationwide population-based cohort study.1 passage
• MRI and glymphatic system.1 passage
• Management characteristics and prognosis after stroke in China: findings from a large nationwide stroke registry.1 passage
• Mechanical thrombectomy in children and adolescents: report of five cases and literature review.1 passage
• Mechanical thrombectomy in patients with M1 occlusion and NIHSS score ≤5: a single-centre experience.1 passage
• Mechanisms of hydrocephalus after intraventricular haemorrhage in adults.1 passage
• Metabolic syndrome, intracranial arterial stenosis and cerebral small vessel disease in community-dwelling populations.1 passage
• Microglial activation after ischaemic stroke.1 passage
• Migraine and stroke.1 passage
• Minimally invasive surgery and transsulcal parafascicular approach in the evacuation of intracerebral haemorrhage.1 passage
• Multimodal imaging findings in normal-appearing white matter of leucoaraiosis: a review.1 passage
• Multimodal management of giant cerebral aneurysms: review of literature and case presentation.1 passage
• Multiple hypointense vessels on susceptibility-weighted imaging predict early neurological deterioration in acute ischaemic stroke patients with severe intracranial large artery stenosis or occlusion receiving intravenous thrombolysis.1 passage
• Neuroimaging studies on cognitive impairment due to cerebral small vessel disease.1 passage
• Neurological outcomes of untreated brainstem cavernous malformations in a prospective observational cohort and literature review.1 passage
• Night-time diastolic blood pressure variability relates to stroke recurrence in patients who had ischaemic stroke with small artery occlusion.1 passage
• No association between elevated homocysteine levels and carotid atherosclerosis in a rural population in China.1 passage
• No benefit of flat head positioning in early moderate-severe acute ischaemic stroke: a HeadPoST study subgroup analysis.1 passage
• Non-coding RNA and neuroinflammation: implications for the therapy of stroke.1 passage
• Non-compliant and compliant balloons for endovascular rescue therapy of cerebral vasospasm after spontaneous subarachnoid haemorrhage: experiences of a single-centre institution with radiological follow-up of the treated vessel segments.1 passage
• Novel role of STAT3 in microglia-dependent neuroinflammation after experimental subarachnoid haemorrhage.1 passage
• Off-hour effect is not significant in endovascular treatment for anterior circulation large vessel occlusion in a multicentre registry.1 passage
• Outcome of multimodal MRI-guided intravenous thrombolysis in patients with stroke with unknown time of onset.1 passage
• Outcomes of Medicare beneficiaries hospitalised with transient ischaemic attack and stratification using the ABCD1 passage
• Patent foramen ovale and cryptogenic stroke: diagnosis and updates in secondary stroke prevention.1 passage
• Patterns of antidepressant therapy and clinical outcomes among ischaemic stroke survivors.1 passage
• Perfusion and plaque evaluation to predict recurrent stroke in symptomatic middle cerebral artery stenosis.1 passage
• Perspective and future of evidence-based medicine.1 passage
• Pertussis toxin-induced inflammatory response exacerbates intracerebral haemorrhage and ischaemic stroke in mice.1 passage
• Phenotypic ASCOD characterisations of ischaemic stroke in the young at an urban tertiary care centre.1 passage
• Plasma from healthy donors protects blood-brain barrier integrity via FGF21 and improves the recovery in a mouse model of cerebral ischaemia.1 passage
• PolyvasculaR Evaluation for Cognitive Impairment and vaScular Events (PRECISE)-a population-based prospective cohort study: rationale, design and baseline participant characteristics.1 passage
• Poststroke seizure: optimising its management.1 passage
• Predicting long-term outcomes in acute intracerebral haemorrhage using delayed prognostication scores.1 passage
• Prediction of large vessel occlusion for ischaemic stroke by using the machine learning model random forests.1 passage
• Prestroke selective serotonin reuptake inhibitor use and functional outcomes after ischaemic stroke.1 passage
• Procedural complexity independent of P2Y12 reaction unit (PRU) values is associated with acute in situ thrombosis in Pipeline flow diversion of cerebral aneurysms.1 passage
• Prognostic value of systemic immune-inflammation index in acute/subacute patients with cerebral venous sinus thrombosis.1 passage
• Prominent juxtacortical white matter lesion hallmarks1 passage
• Providing uninterrupted care during COVID-19 pandemic: experience from Beijing Tiantan Hospital.1 passage
• Quantitative angiographic haemodynamic evaluation of bypasses for complex aneurysms: a preliminary study.1 passage
• Rationale and design of Patient-centered Retrospective Observation of Guideline-Recommended Execution for Stroke Sufferers in China: China PROGRESS.1 passage
• Recanalisation therapy in patients with acute ischaemic stroke caused by large artery occlusion: choice of therapeutic strategy according to underlying aetiological mechanism?1 passage
• Red blood cell distribution width and ischaemic stroke.1 passage
• Registry report on prediction by Pocock cardiovascular score of cerebral microemboli acutely following carotid endarterectomy.1 passage
• Relationship between nitrate headache and outcome in patients with acute stroke: results from the efficacy of nitric oxide in stroke (ENOS) trial.1 passage
• Remote ischaemic conditioning for stroke: unanswered questions and future directions.1 passage
• Remote platelet function testing using P-selectin expression in patients with recent cerebral ischaemia on clopidogrel.1 passage
• Resource utilisation among patients transferred for intracerebral haemorrhage.1 passage
• Review of acute ischaemic stroke in Pakistan: progress in management and future perspectives.1 passage
• Risk factors associated with 90-day recurrent stroke in patients on dual antiplatelet therapy for minor stroke or high-risk TIA: a subgroup analysis of the CHANCE trial.1 passage
• Risk factors for carotid plaque progression after optimising the risk factor treatment: substudy results of the Atherosclerotic Plaque Characteristics Associated with a Progression Rate of the Plaque and a Risk of Stroke in Patients with the carotid Bifurcation Plaque Study (ANTIQUE).1 passage
• Risk factors of haemorrhagic transformation for acute ischaemic stroke in Chinese patients receiving intravenous recombinant tissue plasminogen activator: a systematic review and meta-analysis.1 passage
• Risk of ischaemic stroke in patients with transient global amnesia: a propensity-matched cohort study.1 passage
• Role of depressive symptoms in cardiometabolic diseases and subsequent transitions to all-cause mortality: an application of multistate models in a prospective cohort study.1 passage
• Role of endovascular embolisation for curative treatment of intracranial non-Galenic pial arteriovenous fistula.1 passage
• Safety and efficacy of Edaravone Dexborneol versus edaravone for patients with acute ischaemic stroke: a phase II, multicentre, randomised, double-blind, multiple-dose, active-controlled clinical trial.1 passage
• Safety and efficacy of oral antiplatelet for patients who had acute ischaemic stroke undergoing endovascular therapy.1 passage
• Safety and efficacy of tenecteplase versus alteplase in patients with acute ischaemic stroke (TRACE): a multicentre, randomised, open label, blinded-endpoint (PROBE) controlled phase II study.1 passage
• Safety of endovascular therapy for symptomatic intracranial artery stenosis: a national prospective registry.1 passage
• Safety of tirofiban and dual antiplatelet therapy in treating intracranial aneurysms.1 passage
• Secondary prevention medication persistence and prognosis of acute ischaemic stroke or transient ischaemic attack.1 passage
• Serum bilirubin and ischaemic stroke: a review of literature.1 passage
• Sex-specific differences in white matter microvascular integrity after ischaemic stroke.1 passage
• Shared decision-making in stroke: an evolving approach to improved patient care.1 passage
• Shenzhen stroke emergency map improves access to rt-PA for patients with acute ischaemic stroke.1 passage
• Shuxuetong for Prevention of recurrence in Acute Cerebrovascular events with Embolism (SPACE) trial: rationale and design.1 passage
• Significant flow velocity reduction at the intracranial aneurysm neck after endovascular treatment leads to favourable angiographic outcome: a prospective study.1 passage
• Sleep apnoea and stroke.1 passage
• Smoking influences outcome in patients who had thrombolysed ischaemic stroke: the ENCHANTED study.1 passage
• Staged angioplasty versus regular carotid artery stenting in patients with carotid artery stenosis at high risk of hyperperfusion: a randomised clinical trial.1 passage
• Staged carotid artery angioplasty and stenting for patients with high-grade carotid stenosis with high risk of developing hyperperfusion injury: a retrospective analysis of 44 cases.1 passage
• Statin treatment for unruptured intracranial aneurysms study: a study protocol for a double-blind, placebo-controlled trial.1 passage
• Stem cell treatment improves post stroke neurological outcomes: a comparative study in male and female rats.1 passage
• Stenting for intracranial stenosis: potential future for the prevention of disabling or fatal stroke.1 passage
• Stenting for symptomatic intracranial arterial stenosis in China: 1-year outcome of a multicentre registry study.1 passage
• Stereotactic aspiration for hypertensive intracerebral haemorrhage in a Chinese population: a retrospective cohort study.1 passage
• Strategy for reliable identification of ischaemic stroke, thrombolytics and thrombectomy in large administrative databases.1 passage
• Stroke care during the COVID-19 outbreak in Spain: the experience of Spanish stroke units.1 passage
• Stroke in COVID-19: a single-centre initial experience in a hotspot of the pandemic.1 passage
• Stroke mechanisms and outcomes of isolated symptomatic basilar artery stenosis.1 passage
• Stroke-induced immunosuppression and poststroke infection.1 passage
• Taking care of volunteers in a stroke trial: a new assisted-management strategy.1 passage
• Tandem cervical carotid stenting for stenosis with flow diversion embolisation for the treatment of intracranial aneurysms.1 passage
• Targeting NAMPT as a therapeutic strategy against stroke.1 passage
• Targeting the SUMO pathway for neuroprotection in brain ischaemia.1 passage
• Tenecteplase Reperfusion therapy in Acute ischaemic Cerebrovascular Events-II (TRACE II): rationale and design.1 passage
• The American Heart Association's Get With the Guidelines (GWTG)-Stroke development and impact on stroke care.1 passage
• The Chinese Stroke Association scientific statement: intravenous thrombolysis in acute ischaemic stroke.1 passage
• The Third China National Stroke Registry (CNSR-III) for patients with acute ischaemic stroke or transient ischaemic attack: design, rationale and baseline patient characteristics.1 passage
• The efficacy and safety of endovascular recanalization of occluded large cerebral arteries during the subacute phase of cerebral infarction: a case series report.1 passage
• The progress of telestroke in China.1 passage
• Therapeutic application of exosomes in ischaemic stroke.1 passage
• Thrombolysis with alteplase 3-4.5 hours after acute ischaemic stroke: the first multicentre, phase III trial in China.1 passage
• Too Young to Have a Stroke?-a Global Health Crisis.1 passage
• Tranexamic acid for acute intracerebral haemorrhage growth based on imaging assessment (TRAIGE): a multicentre, randomised, placebo-controlled trial.1 passage
• Tranexamic acid for intracerebral haemorrhage within 2 hours of onset: protocol of a phase II randomised placebo-controlled double-blind multicentre trial.1 passage
• Transradial approach for acute stroke intervention: technical procedure and clinical outcomes.1 passage
• Transradial versus transfemoral access for anterior circulation mechanical thrombectomy: analysis of 375 consecutive cases.1 passage
• Treating ischaemic stroke with intravenous tPA beyond 4.5 hours under the guidance of a MRI DWI/T2WI mismatch was safe and effective.1 passage
• Trend of declining stroke mortality in China: reasons and analysis.1 passage
• Trends and predictors of myocardial infarction or vascular death after ischaemic stroke or TIA in China, 2007-2018: insights from China National Stroke Registries.1 passage
• Update in the treatment of extracranial atherosclerotic disease for stroke prevention.1 passage
• Update in the treatment of intracranial atherosclerotic disease.1 passage
• Update on cell therapy for stroke.1 passage
• Update on cerebral small vessel disease: a dynamic whole-brain disease.1 passage
• Updates in arteriovenous malformation management: the post-ARUBA era.1 passage
• Updates in the management of cranial dural arteriovenous fistula.1 passage
• Use of HINTS in the acute vestibular syndrome. An Overview.1 passage
• Use of intravenous tissue plasminogen activator and hospital costs for patients with acute ischaemic stroke aged 18-64 years in the USA.1 passage
• Use of pCONUS HPC for the treatment of unruptured wide-necked bifurcation aneurysms: early clinical experience using single antiplatelet therapy.1 passage
• Utility of current thrombophilia screening in young patients with stroke and TIA.1 passage
• Validation of risk scoring models for predicting stroke-associated pneumonia in patients with ischaemic stroke.1 passage
• Who may benefit from lower dosages of intravenous tissue plasminogen activator? Results from a cluster data analysis.1 passage
• Whole genome sequencing of 10K patients with acute ischaemic stroke or transient ischaemic attack: design, methods and baseline patient characteristics.1 passage
• Worldwide 1-month case fatality of ischaemic stroke and the temporal trend.1 passage
• Would integrated Western and traditional Chinese medicine have more benefits for stroke rehabilitation? A systematic review and meta-analysis.1 passage
• sTWEAK is a marker of early haematoma growth and leukoaraiosis in intracerebral haemorrhage.1 passage